Patient Satisfaction with Aesthetic Outcomes Following OnabotulinumtoxinA Treatment for Chronic Migraine: A Cross-Sectional Study

OnabotulinumtoxinA (OnaBoNT-A) is approved for chronic migraine prevention and follows the PREEMPT protocol with injections in the glabellar and forehead regions. While aesthetic changes are considered a side effect, their effect on patient satisfaction has not been thoroughly assessed. This study e...

Full description

Bibliographic Details
Published in:Toxins
Main Authors: Magdalena Boczarska-Jedynak, Marta Bott-Karoń, Karol Marschollek, Mariola Antolak, Maciej Świat, Marta Waliszewska-Prosół
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Subjects:
aesthetic medicine
onabotulinumtoxinA
chronic migraine
PREEMPT paradigm
wrinkles
Online Access:https://www.mdpi.com/2072-6651/17/6/292

Internet

https://www.mdpi.com/2072-6651/17/6/292

Similar Items